SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 1,156.54 |
| Enterprise Value ($M) | 752.17 |
| Book Value ($M) | -526.44 |
| Book Value / Share | -3.29 |
| Price / Book | -2.20 |
| NCAV ($M) | -1,135.24 |
| NCAV / Share | -7.09 |
| Price / NCAV | -1.02 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.17 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.93 |
| Current Ratio | 0.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,103.68 |
| Assets | 1,712.48 |
| Liabilities | 2,238.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.63 | 0.00 | |
| 13G/A | State Street Corp | 4.32 | -63.84 | |
| 13G/A | SK Bioscience Co., Ltd. | 4.60 | 0.00 | |
| 13D/A | Shah Capital Management | 7.90 | 2.46 | |
| 13G/A | Morgan Stanley | 1.80 | -66.42 | |
| 13G/A | BlackRock, Inc. | 7.10 | 75.45 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| . UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,898,346 | 8,205,172 | 23.14 | |
| 1,810,301 | 7,805,304 | 23.19 | |
| 1,293,323 | 6,747,916 | 19.17 | |
| 1,536,262 | 8,175,127 | 18.79 | |
| 2,923,421 | 12,232,805 | 23.90 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NKTX – Nkarta, Inc. | NMRA – Neumora Therapeutics, Inc. |
| NUVL – Nuvalent, Inc. | NXTC – NextCure, Inc. |
| OGI – Organigram Holdings Inc. |